William Blair analyst Tim Mulrooney downgrades Kforce (NASDAQ:KFRC) from Outperform to Market Perform.
AVITA Medical Announces Achievement Of Co-Primary Endpoints In Updated Analysis Of Pivotal Trial Of RECELL System For Soft Tissue Repair
AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)))), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today
